A Phase I, Placebo Controlled, Randomised, Double Blind Two-Way Crossover Study to Investigate the Dose Response and Efficacy of Single and Repeat Doses of GW842166 in Healthy Volunteers Using Pharmacodynamic Pain Assessments
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2015
At a glance
- Drugs GW 842166X (Primary)
- Indications Dental pain; Musculoskeletal pain
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 14 Dec 2014 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 12 Jun 2008 Status changed from initiated to discontinued as reported by ClinicalTrials.gov.
- 29 Nov 2007 New trial record.